No retraction, correction or concern found when last checked on Oct 21, 2026.

Fungal-Bacterial Interactions in Health and Disease

Wibke Krüger, Sarah Vielreicher, Mario Kapitan and 2 more

Pathogens · 2019 · Review · CC BY

doi:10.3390/pathogens8020070

Abstract

Fungi and bacteria encounter each other in various niches of the human body. There, they interact directly with one another or indirectly via the host response. In both cases, interactions can affect host health and disease. In the present review, we summarized current knowledge on fungal-bacterial interactions during their commensal and pathogenic lifestyle. We focus on distinct mucosal niches: the oral cavity, lung, gut, and vagina. In addition, we describe interactions during bloodstream and wound infections and the possible consequences for the human host.

References 359

1.
Albert M.J., Mathan V.I., Baker S.J. Vitamin B12 synthesis by human small intestinal bacteria. Nature. 1980;283:781-782.
Not in our library10.1038/283781a0
2.
Bruce A.W., Chadwick P., Hassan A., VanCott G.F. Recurrent urethritis in women. Can. Med. Assoc. J. 1973;108:973-976.
Not in our library
3.
Enaud R., Vandenborght L.-E., Coron N., Bazin T., Prevel R., Schaeverbeke T., Berger P., Fayon M., Lamireau T., Delhaes L. The mycobiome: A neglected component in the microbiota-gut-brain axis. Microorganisms. 2018;6:22.
Not in our library10.3390/microorganisms6010022
4.
Turnbaugh P.J., Ley R.E., Hamady M., Fraser-Liggett C.M., Knight R., Gordon J.I. The human microbiome project. Nature. 2007;449:804-810.
Not in our library10.1038/nature06244
5.
Characterization of the Oral Fungal Microbiome (Mycobiome) in Healthy Individuals · 2010
No notice
6.
Iliev I.D., Funari V.A., Taylor K.D., Nguyen Q., Reyes C.N., Strom S.P., Brown J., Becker C.A., Fleshner P.R., Dubinsky M., et al. Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis. Science. 2012;336:1314-1317.
Not in our library10.1126/science.1221789
7.
Huttenhower C., Gevers D., Knight R., Abubucker S., Badger J.H., Chinwalla A.T., Creasy H.H., Earl A.M., FitzGerald M.G., Fulton R.S., et al. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486:207.
Not in our library10.1038/nature11234
8.
Revised Estimates for the Number of Human and Bacteria Cells in the Body · 2016
No notice
9.
Brown G.D., Denning D.W., Gow N.A., Levitz S.M., Netea M.G., White T.C. Hidden killers: Human fungal infections. Sci. Transl. Med. 2012;4:165rv13.
Not in our library10.1126/scitranslmed.3004404
10.
Hermann C., Hermann J., Munzel U., Ruchel R. Bacterial flora accompanying Candida yeasts in clinical specimens. Mycoses. 1999;42:619-627.
Not in our library10.1046/j.1439-0507.1999.00519.x
11.
Kim S.H., Yoon Y.K., Kim M.J., Sohn J.W. Risk factors for and clinical implications of mixed Candida/bacterial bloodstream infections. Clin. Microbiol. Infect. 2013;19:62-68.
Not in our library10.1111/j.1469-0691.2012.03906.x
12.
Klotz S.A., Chasin B.S., Powell B., Gaur N.K., Lipke P.N. Polymicrobial bloodstream infections involving Candida species: Analysis of patients and review of the literature. Diagn. Microbiol. Infect. Dis. 2007;59:401-406.
Not in our library10.1016/j.diagmicrobio.2007.07.001
13.
Reno J., Doshi S., Tunali A.K., Stein B., Farley M.M., Ray S.M., Jacob J.T. Epidemiology of methicillin-resistant Staphylococcus aureus bloodstream coinfection among adults with candidemia in Atlanta (GA) 2008-2012. Infect. Control Hosp. Epidemiol. 2015;36:1298-1304.
Not in our library10.1017/ice.2015.185
14.
Kett D.H., Azoulay E., Echeverria P.M., Vincent J.L. Candida bloodstream infections in intensive care units: Analysis of the extended prevalence of infection in intensive care unit study. Crit. Care Med. 2011;39:665-670.
Not in our library10.1097/ccm.0b013e318206c1ca
15.
Chotirmall S.H., Greene C.M., McElvaney N.G. Candida species in cystic fibrosis: A road less travelled. Med. Mycol. J. 2010;48:114-124.
Not in our library10.3109/13693786.2010.503320
16.
Amin R., Dupuis A., Aaron S.D., Ratjen F. The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis. Chest. 2010;137:171-176.
Not in our library10.1378/chest.09-1103
17.
Characterization of the Vaginal Micro- and Mycobiome in Asymptomatic Reproductive-Age Estonian Women · 2013
No notice
18.
Charlson E.S., Diamond J.M., Bittinger K., Fitzgerald A.S., Yadav A., Haas A.R., Bushman F.D., Collman R.G. Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant. Am. J. Respir. Crit. Care Med. 2012;186:536-545.
Not in our library10.1164/rccm.201204-0693oc
19.
Botterel F., Angebault C., Cabaret O., Stressmann F.A., Costa J.M., Wallet F., Wallaert B., Bruce K., Delhaes L. Fungal and bacterial diversity of airway microbiota in adults with cystic fibrosis: Concordance between conventional methods and ultra-deep sequencing, and their practical use in the clinical laboratory. Mycopathologia. 2018;183:171-183.
Not in our library10.1007/s11046-017-0185-x
20.
Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn’s Disease · 2016
No notice
21.
Saxena R., Mittal P., Clavaud C., Dhakan D.B., Hegde P., Veeranagaiah M.M., Saha S., Souverain L., Roy N., Breton L., et al. Comparison of healthy and dandruff scalp microbiome reveals the role of commensals in scalp health. Front. Cell. Infect. Microbiol. 2018;8:346.
Not in our library10.3389/fcimb.2018.00346
22.
Vesty A., Gear K., Biswas K., Radcliff F.J., Taylor M.W., Douglas R.G. Microbial and inflammatory-based salivary biomarkers of head and neck squamous cell carcinoma. Clin. Exp. Dent. Res. 2018;4:255-262.
Not in our library10.1002/cre2.139
23.
Fukui Y., Aoki K., Ishii Y., Tateda K. The palatine tonsil bacteriome, but not the mycobiome, is altered in HIV infection. BMC Microbiol. 2018;18:127.
Not in our library10.1186/s12866-018-1274-9
24.
Enterobacteriaceae are essential for the modulation of colitis severity by fungi · 2018
No notice
25.
Jurdi N.E., Filali-Mouhim A., Salem I., Retuerto M., Dambrosio N.M., Baer L., Lazarus H.M., Caimi P., Cooper B., Tomlinson B., et al. Gastrointestinal microbiome and mycobiome changes during autologous transplantation for multiple myeloma: Results of a prospective pilot study. Biol. Blood Marrow Transplant. 2019.
Not in our library10.1016/j.bbmt.2018.12.835
26.
Kragelund C., Keller M.K. The oral microbiome in oral lichen planus during a 1-year randomized clinical trial. Oral Dis. 2018;25:327-338.
Not in our library10.1111/odi.12961
27.
Fungi of the Murine Gut: Episodic Variation and Proliferation during Antibiotic Treatment · 2013
No notice
28.
Evaluating the Impact of DNA Extraction Method on the Representation of Human Oral Bacterial and Fungal Communities. · 2017
Not checked
29.
Choice of bacterial DNA extraction method from fecal material influences community structure as evaluated by metagenomic analysis · 2014
No notice
30.
Underhill D.M., Iliev I.D. The mycobiota: Interactions between commensal fungi and the host immune system. Nat. Rev. Immunol. 2014;14:405-416.
Not in our library10.1038/nri3684
31.
Tang J., Iliev I.D., Brown J., Underhill D.M., Funari V.A. Mycobiome: Approaches to analysis of intestinal fungi. J. Immunol. Methods. 2015;421:112-121.
Not in our library10.1016/j.jim.2015.04.004
32.
Chen Y., Chen Z., Guo R., Chen N., Lu H., Huang S., Wang J., Li L. Correlation between gastrointestinal fungi and varying degrees of chronic hepatitis B virus infection. Diagn. Microbiol. Infect. Dis. 2011;70:492-498.
Not in our library10.1016/j.diagmicrobio.2010.04.005
33.
Brogden K.A., Guthmiller J.M., Taylor C.E. Human polymicrobial infections. Lancet. 2005;365:253-255.
Not in our library10.1016/s0140-6736(05)70155-0
34.
Allison D.L., Willems H.M., Jayatilake J.A., Bruno V.M., Peters B.M., Shirtliff M.E. Candida-bacteria interactions: Their impact on human disease. Microbiol. Spectr. 2016;4.
Not in our library10.1128/microbiolspec.vmbf-0030-2016
35.
Peters B.M., Jabra-Rizk M.A., O’May G.A., Costerton J.W., Shirtliff M.E. Polymicrobial interactions: Impact on pathogenesis and human disease. Clin. Microbiol. Rev. 2012;25:193-213.
Not in our library10.1128/cmr.00013-11
36.
Förster T.M., Mogavero S., Dräger A., Graf K., Polke M., Jacobsen I.D., Hube B. Enemies and brothers in arms: Candida albicans and gram-positive bacteria. Cell. Microbiol. 2016;18:1709-1715.
Not in our library10.1111/cmi.12657
37.
Kapitan M., Niemiec M.J., Steimle A., Frick J.S., Jacobsen I.D. Fungi as part of the microbiota and interactions with intestinal bacteria. Curr. Top. Microbiol. Immunol. 2018;1:1-37.
Not in our library10.1007/82_2018_117
38.
Wargo M.J., Hogan D.A. Fungal-bacterial interactions: A mixed bag of mingling microbes. Curr. Opin. Microbiol. 2006;9:359-364.
Not in our library10.1016/j.mib.2006.06.001
39.
Leclair L.W., Hogan D.A. Mixed bacterial-fungal infections in the CF respiratory tract. Med. Mycol. 2010;48:125-132.
Not in our library10.3109/13693786.2010.521522
40.
Candida albicans Interactions with Bacteria in the Context of Human Health and Disease · 2010
No notice
41.
Development of Complex Models to Study Co- and Polymicrobial Infections and Diseases. · 2016
Not checked
42.
Peleg A.Y., Hogan D.A., Mylonakis E. Medically important bacterial–fungal interactions. Nat. Rev. Microbiol. 2010;8:340.
Not in our library10.1038/nrmicro2313
43.
Shirtliff M.E., Peters B.M., Jabra-Rizk M.A. Cross-kingdom interactions: Candida albicans and bacteria. FEMS Microbiol. Lett. 2009;299:1-8.
Not in our library10.1111/j.1574-6968.2009.01668.x
44.
A Core Human Microbiome as Viewed through 16S rRNA Sequence Clusters · 2012
No notice
45.
Klimesova K., Jiraskova Zakostelska Z., Tlaskalova-Hogenova H. Oral bacterial and fungal microbiome impacts colorectal carcinogenesis. Front. Microbiol. 2018;9:774.
Not in our library10.3389/fmicb.2018.00774
46.
Redefining the Human Oral Mycobiome with Improved Practices in Amplicon-based Taxonomy: Discovery of Malassezia as a Prominent Commensal · 2014
No notice
47.
Disordered Microbial Communities in Asthmatic Airways · 2010
No notice
48.
Charlson E.S., Bittinger K., Haas A.R., Fitzgerald A.S., Frank I., Yadav A., Bushman F.D., Collman R.G. Topographical continuity of bacterial populations in the healthy human respiratory tract. Am. J. Respir. Crit. Care Med. 2011;184:957-963.
Not in our library10.1164/rccm.201104-0655oc
49.
Analysis of the Lung Microbiome in the “Healthy” Smoker and in COPD · 2011
No notice
50.
Differences in fungi present in induced sputum samples from asthma patients and non-atopic controls: a community based case control study · 2013
No notice
51.
Mailhe M., Ricaboni D., Vitton V., Gonzalez J.-M., Bachar D., Dubourg G., Cadoret F., Robert C., Delerce J., Levasseur A. Repertoire of the gut microbiota from stomach to colon using culturomics and next-generation sequencing. BMC Microbiol. 2018;18:157.
Not in our library10.1186/s12866-018-1304-7
52.
Eckburg P.B., Bik E.M., Bernstein C.N., Purdom E., Dethlefsen L., Sargent M., Gill S.R., Nelson K.E., Relman D.A. Diversity of the human intestinal microbial flora. Science. 2005;308:1635-1638.
Not in our library10.1126/science.1110591
53.
The gut mycobiome of the Human Microbiome Project healthy cohort · 2017
No notice
54.
Archaea and Fungi of the Human Gut Microbiome: Correlations with Diet and Bacterial Residents · 2013
No notice
55.
Nogueira M., Pereira L., Jenull S., Kuchler K., Lion T. Klebsiella pneumoniae prevents spore germination and hyphal development of Aspergillus species. Sci. Rep. 2019;9:218.
Not in our library10.1038/s41598-018-36524-8
56.
Mowat E., Rajendran R., Williams C., McCulloch E., Jones B., Lang S., Ramage G. Pseudomonas aeruginosa and their small diffusible extracellular molecules inhibit Aspergillus fumigatus biofilm formation. FEMS Microbiol. Lett. 2010;313:96-102.
Not in our library10.1111/j.1574-6968.2010.02130.x
57.
Gaddy J.A., Tomaras A.P., Actis L.A. The Acinetobacter baumannii 19606 OmpA protein plays a role in biofilm formation on abiotic surfaces and in the interaction of this pathogen with eukaryotic cells. Infect. Immun. 2009;77:3150-3160.
Not in our library10.1128/iai.00096-09
58.
Bor B., Cen L., Agnello M., Shi W., He X. Morphological and physiological changes induced by contact-dependent interaction between Candida albicans and Fusobacterium nucleatum. Sci. Rep. 2016;6:27956.
Not in our library10.1038/srep27956
59.
Pidwill G.R., Rego S., Jenkinson H.F., Lamont R.J., Nobbs A.H. Coassociation between Group B Streptococcus and Candida albicans promotes interactions with vaginal epithelium. Infect. Immun. 2018;86:e00669-17.
Not in our library10.1128/iai.00669-17
60.
Hogan D.A., Kolter R. Pseudomonas-Candida interactions: An ecological role for virulence factors. Science. 2002;296:2229-2232.
Not in our library10.1126/science.1070784
61.
Brand A., Barnes J.D., Mackenzie K.S., Odds F.C., Gow N.A. Cell wall glycans and soluble factors determine the interactions between the hyphae of Candida albicans and Pseudomonas aeruginosa. FEMS Microbiol. Lett. 2008;287:48-55.
Not in our library10.1111/j.1574-6968.2008.01301.x
62.
Peters B.M., Ovchinnikova E.S., Krom B.P., Schlecht L.M., Zhou H., Hoyer L.L., Busscher H.J., van der Mei H.C., Jabra-Rizk M.A., Shirtliff M.E. Staphylococcus aureus adherence to Candida albicans hyphae is mediated by the hyphal adhesin Als3p. Microbiology. 2012;158:2975-2986.
Not in our library10.1099/mic.0.062109-0
63.
Schlecht L.M., Peters B.M., Krom B.P., Freiberg J.A., Hansch G.M., Filler S.G., Jabra-Rizk M.A., Shirtliff M.E. Systemic Staphylococcus aureus infection mediated by Candida albicans hyphal invasion of mucosal tissue. Microbiology. 2015;161:168-181.
Not in our library10.1099/mic.0.083485-0
64.
Kong E.F., Kucharikova S., Van Dijck P., Peters B.M., Shirtliff M.E., Jabra-Rizk M.A. Clinical implications of oral candidiasis: Host tissue damage and disseminated bacterial disease. Infect. Immun. 2015;83:604-613.
Not in our library10.1128/iai.02843-14
65.
Beaussart A., Herman P., El-Kirat-Chatel S., Lipke P.N., Kucharikova S., Van Dijck P., Dufrene Y.F. Single-cell force spectroscopy of the medically important Staphylococcus epidermidis-Candida albicans interaction. Nanoscale. 2013;5:10894-10900.
Not in our library10.1039/c3nr03272h
66.
A proposed mechanism for the interaction between the Candida albicans Als3 adhesin and streptococcal cell wall proteins · 2014
Not checked
67.
Silverman R.J., Nobbs A.H., Vickerman M.M., Barbour M.E., Jenkinson H.F. Interaction of Candida albicans cell wall Als3 protein with Streptococcus gordonii SspB adhesin promotes development of mixed-species communities. Infect. Immun. 2010;78:4644-4652.
Not in our library10.1128/iai.00685-10
68.
Bamford C.V., D’mello A., Nobbs A.H., Dutton L.C., Vickerman M.M., Jenkinson H.F. Streptococcus gordonii modulates Candida albicans biofilm formation through intergeneric communication. Infect. Immun. 2009;77:3696-3704.
Not in our library10.1128/iai.00438-09
69.
Aspergillus fumigatus Inhibits Pseudomonas aeruginosa in Co-culture: Implications of a Mutually Antagonistic Relationship on Virulence and Inflammation in the CF Airway · 2018
Not checked
70.
Kerr J., Taylor G., Rutman A., Høiby N., Cole P., Wilson R. Pseudomonas aeruginosa pyocyanin and 1-hydroxyphenazine inhibit fungal growth. J. Clin. Pathol. 1999;52:385-387.
Not in our library10.1136/jcp.52.5.385
71.
Bachtiar E.W., Bachtiar B.M., Jarosz L.M., Amir L.R., Sunarto H., Ganin H., Meijler M.M., Krom B.P. AI-2 of Aggregatibacter actinomycetemcomitans inhibits Candida albicans biofilm formation. Front. Cell. Infect. Microbiol. 2014;4:94.
Not in our library10.3389/fcimb.2014.00094
72.
Interspecies Interactions between <named-content content-type="genus-species">Clostridium difficile</named-content> and <named-content content-type="genus-species">Candida albicans</named-content> · 2016
Not checked
73.
Bandara H.M., Cheung B.P.K., Watt R.M., Jin L.J., Samaranayake L.P. Secretory products of Escherichia coli biofilm modulate Candida biofilm formation and hyphal development. J. Investig. Clin. Dent. 2013;4:186-199.
Not in our library10.1111/jicd.12048
74.
Cabral D.J., Penumutchu S., Norris C., Morones-Ramirez J.R., Belenky P. Microbial competition between Escherichia coli and Candida albicans reveals a soluble fungicidal factor. Microb. Cell. 2018;5:249-255.
Not in our library10.15698/mic2018.05.631
75.
Graham C.E., Cruz M.R., Garsin D.A., Lorenz M.C. Enterococcus faecalis bacteriocin EntV inhibits hyphal morphogenesis, biofilm formation, and virulence of Candida albicans. Proc. Natl. Acad. Sci. USA. 2017;114:4507-4512.
Not in our library10.1073/pnas.1620432114
76.
Cruz M.R., Graham C.E., Gagliano B.C., Lorenz M.C., Garsin D.A. Enterococcus faecalis inhibits hyphal morphogenesis and virulence of Candida albicans. Infect. Immun. 2013;81:189-200.
Not in our library10.1128/iai.00914-12
77.
Isolation of Vaginal Lactobacilli and Characterization of Anti-Candida Activity · 2015
No notice
78.
Okkers D.J., Dicks L.M.T., Silvester M., Joubert J.J., Odendaal H.J. Characterization of pentocin TV35b, a bacteriocin-like peptide isolated from Lactobacillus pentosus with a fungistatic effect on Candida albicans. J. Appl. Microbiol. 1999;87:726-734.
Not in our library10.1046/j.1365-2672.1999.00918.x
79.
Kaewsrichan J., Peeyananjarassri K., Kongprasertkit J. Selection and identification of anaerobic lactobacilli producing inhibitory compounds against vaginal pathogens. FEMS Immunol. Med. Microbiol. 2006;48:75-83.
Not in our library10.1111/j.1574-695x.2006.00124.x
80.
Noverr M.C., Huffnagle G.B. Regulation of Candida albicans morphogenesis by fatty acid metabolites. Infect. Immun. 2004;72:6206-6210.
Not in our library10.1128/iai.72.11.6206-6210.2004
81.
Cugini C., Calfee M.W., Farrow J.M., Morales D.K., Pesci E.C., Hogan D.A. Farnesol, a common sesquiterpene, inhibits PQS production in Pseudomonas aeruginosa. Mol. Microbiol. 2007;65:896-906.
Not in our library10.1111/j.1365-2958.2007.05840.x
82.
Gibson J., Sood A., Hogan D.A. Pseudomonas aeruginosa-Candida albicans interactions: Localization and fungal toxicity of a phenazine derivative. Appl. Environ. Microbiol. 2009;75:504-513.
Not in our library10.1128/aem.01037-08
83.
Kong E.F., Tsui C., Kucharikova S., Van Dijck P., Jabra-Rizk M.A. Modulation of Staphylococcus aureus response to antimicrobials by the Candida albicans quorum sensing molecule farnesol. Antimicrob. Agents Chemother. 2017;61:e01573-17.
Not in our library10.1128/aac.01573-17
84.
Candida albicans stimulates Streptococcus mutans microcolony development via cross-kingdom biofilm-derived metabolites · 2017
No notice
85.
Vílchez R., Lemme A., Ballhausen B., Thiel V., Schulz S., Jansen R., Sztajer H., Wagner-Döbler I. Streptococcus mutans inhibits Candida albicans hyphal formation by the fatty acid signaling molecule trans-2-decenoic acid (SDSF). Chembiochem. 2010;11:1552-1562.
Not in our library10.1002/cbic.201000086
86.
Jarosz L.M., Deng D.M., van der Mei H.C., Crielaard W., Krom B.P. Streptococcus mutans competence-stimulating peptide inhibits Candida albicans hypha formation. Eukaryot Cell. 2009;8:1658-1664.
Not in our library10.1128/ec.00070-09
87.
Kim Y., Mylonakis E. Killing of Candida albicans filaments by Salmonella enterica serovar Typhimurium is mediated by SopB effectors, parts of a type III secretion system. Eukaryot Cell. 2011;10:782-790.
Not in our library10.1128/ec.00014-11
88.
Frases S., Chaskes S., Dadachova E., Casadevall A. Induction by Klebsiella aerogenes of a melanin-like pigment in Cryptococcus neoformans. Appl. Environ. Microbiol. 2006;72:1542-1550.
Not in our library10.1128/aem.72.2.1542-1550.2006
89.
Smith M.G., Des Etages S.G., Snyder M. Microbial synergy via an ethanol-triggered pathway. Mol. Cell. Biol. 2004;24:3874-3884.
Not in our library10.1128/mcb.24.9.3874-3884.2004
90.
Fox E.P., Cowley E.S., Nobile C.J., Hartooni N., Newman D.K., Johnson A.D. Anaerobic bacteria grow within Candida albicans biofilms and induce biofilm formation in suspension cultures. Cell. Microbiol. 2014;24:2411-2416.
Not in our library10.1016/j.cub.2014.08.057
91.
Boris S., Suárez J.E., Vázquez F., Barbés C. Adherence of human vaginal lactobacilli to vaginal epithelial cells and interaction with uropathogens. Infect. Immun. 1998;66:1985-1989.
Not in our library10.1128/iai.66.5.1985-1989.1998
92.
Donnarumma G., Molinaro A., Cimini D., De Castro C., Valli V., De Gregorio V., De Rosa M., Schiraldi C. Lactobacillus crispatus L1: High cell density cultivation and exopolysaccharide structure characterization to highlight potentially beneficial effects against vaginal pathogens. BMC Microbiol. 2014;14:137-149.
Not in our library10.1186/1471-2180-14-137
93.
Rizzo A., Losacco A., Carratelli C.R. Lactobacillus crispatus modulates epithelial cell defense against Candida albicans through Toll-like receptors 2 and 4, interleukin 8 and human β-defensins 2 and 3. Immun. Lett. 2013;156:102-109.
Not in our library10.1016/j.imlet.2013.08.013
94.
Basson N.J. Competition for glucose between Candida albicans and oral bacteria grown in mixed culture in a chemostat. J. Med. Microbiol. 2000;49:969-975.
Not in our library10.1099/0022-1317-49-11-969
95.
Redefining the Chronic-Wound Microbiome: Fungal Communities Are Prevalent, Dynamic, and Associated with Delayed Healing · 2016
No notice
96.
De Brucker K., Tan Y., Vints K., De Cremer K., Braem A., Verstraeten N., Michiels J., Vleugels J., Cammue B.P., Thevissen K. Fungal β-1, 3-glucan increases ofloxacin-tolerance of Escherichia coli in a polymicrobial E. coli–Candida albicans biofilm. Antimicrob. Agents Chemother. 2015;59:3052-3058.
Not in our library10.1128/aac.04650-14
97.
Adair C.G., Gorman S.P., Feron B.M., Byers L.M., Jones D.S., Goldsmith C.E., Moore J.E., Kerr J.R., Curran M.D., Hogg G. Implications of endotracheal tube biofilm for ventilator-associated pneumonia. Intensive Care Med. 1999;25:1072-1076.
Not in our library10.1007/s001340051014
98.
Bandara H.M., Lam O.L.T., Watt R.M., Jin L.J., Samaranayake L.P. Bacterial lipopolysaccharides variably modulate in vitro biofilm formation of Candida species. J. Med. Microbiol. 2010;59:1225-1234.
Not in our library10.1099/jmm.0.021832-0
99.
Bandara H., K Cheung B., Watt R., Jin L., Samaranayake L. Pseudomonas aeruginosa lipopolysaccharide inhibits Candida albicans hyphae formation and alters gene expression during biofilm development. Mol. Oral Microbiol. 2013;28:54-69.
Not in our library10.1111/omi.12006
100.
Karkowska-Kuleta J., Bartnicka D., Zawrotniak M., Zielinska G., Kierońska A., Bochenska O., Ciaston I., Koziel J., Potempa J., Baster Z., et al. The activity of bacterial peptidylarginine deiminase is important during formation of dual-species biofilm by periodontal pathogen Porphyromonas gingivalis and opportunistic fungus Candida albicans. Pathog. Dis. 2018;76:fty033.
Not in our library10.1093/femspd/fty033
101.
Harriott M.M., Noverr M.C. Candida albicans and Staphylococcus aureus form polymicrobial biofilms: Effects on antimicrobial resistance. Antimicrob. Agents Chemother. 2009;53:3914-3922.
Not in our library10.1128/aac.00657-09
102.
Commensal Protection of Staphylococcus aureus against Antimicrobials by Candida albicans Biofilm Matrix · 2016
No notice
103.
Microbial interactions and differential protein expression in Staphylococcus aureus–Candida albicans dual-species biofilms · 2010
No notice
104.
Adam B., Baillie G.S., Douglas L.J. Mixed species biofilms of Candida albicans and Staphylococcus epidermidis. J. Med. Microbiol. 2002;51:344-349.
Not in our library10.1099/0022-1317-51-4-344
105.
Pammi M., Liang R., Hicks J., Mistretta T.A., Versalovic J. Biofilm extracellular DNA enhances mixed species biofilms of Staphylococcus epidermidis and Candida albicans. BMC Microbiol. 2013;13:257.
Not in our library10.1186/1471-2180-13-257
106.
Diaz P.I., Xie Z., Sobue T., Thompson A., Biyikoglu B., Ricker A., Ikonomou L., Dongari-Bagtzoglou A. Synergistic interaction between Candida albicans and commensal oral streptococci in a novel in vitro mucosal model. Infect. Immun. 2012;80:620-632.
Not in our library10.1128/iai.05896-11
107.
Xu H., Sobue T., Thompson A., Xie Z., Poon K., Ricker A., Cervantes J., Diaz P.I., Dongari-Bagtzoglou A. Streptococcal co-infection augments Candida pathogenicity by amplifying the mucosal inflammatory response. Cell Microb. 2013;16:214-231.
Not in our library10.1111/cmi.12216
108.
Bacterial-derived exopolysaccharides enhance antifungal drug tolerance in a cross-kingdom oral biofilm · 2018
No notice
109.
Falsetta M.L., Klein M.I., Colonne P.M., Scott-Anne K., Gregoire S., Pai C.-H., Gonzalez-Begne M., Watson G., Krysan D.J., Bowen W.H., et al. Symbiotic relationship between Streptococcus mutans and Candida albicans synergizes virulence of plaque biofilm in vivo. Infect. Immun. 2014;82:1968-1981.
Not in our library10.1128/iai.00087-14
110.
Dewhirst F.E., Chen T., Izard J., Paster B.J., Tanner A.C.R., Yu W.-H., Lakshmanan A., Wade W.G. The human oral microbiome. J. Bacteriol. 2010;192:5002-5017.
Not in our library10.1128/jb.00542-10
111.
Arweiler N.B., Netuschil L., Schwiertz A. The oral microbiota. Microbiota of the Human Body: Implications in Health and Disease. 2016;45-60.
Not in our library
112.
Marsh P.D., Do T., Beighton D., Devine D.A. Influence of saliva on the oral microbiota. Periodontol 2000. 2016;70:80-92.
Not in our library10.1111/prd.12098
113.
Zhang Y., Wang X., Li H., Ni C., Du Z., Yan F. Human oral microbiota and its modulation for oral health. Biomed. Pharmacother. 2018;99:883-893.
Not in our library10.1016/j.biopha.2018.01.146
114.
Costerton J.W., Stewart P.S., Greenberg E.P. Bacterial biofilms: A common cause of persistent infections. Science. 1999;284:1318-1322.
Not in our library10.1126/science.284.5418.1318
115.
Azeredo J., Azevedo N.F., Briandet R., Cerca N., Coenye T., Costa A.R., Desvaux M., Di Bonaventura G., Hebraud M., Jaglic Z., et al. Critical review on biofilm methods. Crit. Rev. Microbiol. 2017;43:313-351.
Not in our library10.1080/1040841x.2016.1208146
116.
Harriott M.M., Noverr M.C. Importance of Candida-bacterial polymicrobial biofilms in disease. Trends Microbiol. 2011;19:557-563.
Not in our library10.1016/j.tim.2011.07.004
117.
Arvanitis M., Mylonakis E. Characteristics, clinical relevance, and the role of echinocandins in fungal-bacterial interactions. Clin. Infect. Dis. 2015;61:630-634.
Not in our library10.1093/cid/civ816
118.
Demuyser L., Jabra-Rizk M.A., Van Dijck P. Microbial cell surface proteins and secreted metabolites involved in multispecies biofilms. Pathog. Dis. 2014;70:219-230.
Not in our library10.1111/2049-632x.12123
119.
Defining the healthy "core microbiome" of oral microbial communities · 2009
No notice
120.
Utter D.R., Mark Welch J.L., Borisy G.G. Individuality, stability, and variability of the plaque microbiome. Front. Microbiol. 2016;7:564.
Not in our library10.3389/fmicb.2016.00564
121.
Costello E.K., Lauber C.L., Hamady M., Fierer N., Gordon J.I., Knight R. Bacterial community variation in human body habitats across space and time. Science. 2009;326:1694-1697.
Not in our library10.1126/science.1177486
122.
Stahringer S.S., Clemente J.C., Corley R.P., Hewitt J., Knights D., Walters W.A., Knight R., Krauter K.S. Nurture trumps nature in a longitudinal survey of salivary bacterial communities in twins from early adolescence to early adulthood. Genome Res. 2012;22:2146-2152.
Not in our library10.1101/gr.140608.112
123.
Host lifestyle affects human microbiota on daily timescales · 2014
Corrected
124.
Cameron S.J., Huws S.A., Hegarty M.J., Smith D.P., Mur L.A. The human salivary microbiome exhibits temporal stability in bacterial diversity. FEMS Microbiol. Ecol. 2015;91:91.
Not in our library10.1093/femsec/fiv091
125.
Temporal Stability of the Salivary Microbiota in Oral Health · 2016
No notice
126.
Ding T., Schloss P.D. Dynamics and associations of microbial community types across the human body. Nature. 2014;509:357-360.
Not in our library10.1038/nature13178
127.
Moving pictures of the human microbiome · 2011
No notice
128.
Temporal variability is a personalized feature of the human microbiome · 2014
No notice
129.
Monteiro-da-Silva F., Araujo R., Sampaio-Maia B. Interindividual variability and intraindividual stability of oral fungal microbiota over time. Med. Mycol. 2014;52:498-505.
Not in our library10.1093/mmy/myu027
130.
Selwitz R.H., Ismail A.I., Pitts N.B. Dental caries. Lancet. 2007;369:51-59.
Not in our library10.1016/s0140-6736(07)60031-2
131.
Takahashi N., Nyvad B. The role of bacteria in the caries process: Ecological perspectives. J. Dent. Res. 2011;90:294-303.
Not in our library10.1177/0022034510379602
132.
Costa A.C., Pereira C.A., Junqueira J.C., Jorge A.O. Recent mouse and rat methods for the study of experimental oral candidiasis. Virulence. 2013;4:391-399.
Not in our library10.4161/viru.25199
133.
Millsop J.W., Fazel N. Oral candidiasis. Clin. Dermatol. 2016;34:487-494.
Not in our library10.1016/j.clindermatol.2016.02.022
134.
Chanda W., Joseph T.P., Wang W., Padhiar A.A., Zhong M. The potential management of oral candidiasis using anti-biofilm therapies. Med. Hypotheses. 2017;106:15-18.
Not in our library10.1016/j.mehy.2017.06.029
135.
Jain A., Jain S., Rawat S. Emerging fungal infections among children: A review on its clinical manifestations, diagnosis, and prevention. J. Pharm Bioallied Sci. 2010;2:314-320.
Not in our library10.4103/0975-7406.72131
136.
Dickstein B. Neonatal oral candidiasis: Evaluation of a new chemotherapeutic agent. Drug Des. Dev. Ther. 1964;3:485-488.
Not in our library10.1177/000992286400300811
137.
Dzidic M., Collado M.C., Abrahamsson T., Artacho A., Stensson M., Jenmalm M.C., Mira A. Oral microbiome development during childhood: An ecological succession influenced by postnatal factors and associated with tooth decay. ISME J. 2018;12:2292-2306.
Not in our library10.1038/s41396-018-0204-z
138.
Hoepelman I.M., Dupont B. Oral candidiasis: The clinical challenge of resistance and management. Int. J. Antimicrob. Agents. 1996;6:155-159.
Not in our library10.1016/0924-8579(95)00050-x
139.
Sampaio-Maia B., Monteiro-Silva F. Acquisition and maturation of oral microbiome throughout childhood: An update. Dent. Res. J. 2014;11:291-301.
Not in our library
140.
Hajishengallis G. The inflammophilic character of the periodontitis-associated microbiota. Mol. Oral Microbiol. 2014;29:248-257.
Not in our library10.1111/omi.12065
141.
Canabarro A., Valle C., Farias M.R., Santos F.B., Lazera M., Wanke B. Association of subgingival colonization of Candida albicans and other yeasts with severity of chronic periodontitis. J. Periodontal Res. 2013;48:428-432.
Not in our library10.1111/jre.12022
142.
De-La-Torre J., Quindós G., Marcos-Arias C., Marichalar-Mendia X., Gainza M.L., Eraso E., Acha-Sagredo A., Aguirre-Urizar J.M. Oral Candida colonization in patients with chronic periodontitis. Is there any relationship? Rev. Iberoam Micol. 2018;35:134-139.
Not in our library10.1016/j.riam.2018.03.005
143.
Relationship between Candida albicans and Streptococcus mutans in early childhood caries, evaluated by quantitative PCR [version 1; referees: 2 approved] · 2018
Not checked
144.
De Carvalho F.G., Silva D.S., Hebling J., Spolidorio L.C., Spolidorio D.M.P. Presence of mutans streptococci and Candida spp. in dental plaque/dentine of carious teeth and early childhood caries. Arch. Oral Biol. 2006;51:1024-1028.
Not in our library10.1016/j.archoralbio.2006.06.001
145.
Raja M., Hannan A., Ali K. Association of oral candidal carriage with dental caries in children. Caries Res. 2010;44:272-276.
Not in our library10.1159/000314675
146.
Yang X.Q., Zhang Q., Lu L.Y., Yang R., Liu Y., Zou J. Genotypic distribution of Candida albicans in dental biofilm of chinese children associated with severe early childhood caries. Arch. Oral Biol. 2012;57:1048-1053.
Not in our library10.1016/j.archoralbio.2012.05.012
147.
Beyond Streptococcus mutans: Dental Caries Onset Linked to Multiple Species by 16S rRNA Community Analysis · 2012
No notice
148.
Streptococcus mutans, Candida albicans, and the Human Mouth: A Sticky Situation · 2013
No notice
149.
Streptococcus mutans, Caries and Simulation Models · 2010
No notice
150.
Falsetta M.L., Klein M.I., Lemos J.A., Silva B.B., Agidi S., Scott-Anne K.K., Koo H. Novel antibiofilm chemotherapy targets exopolysaccharide synthesis and stress tolerance in Streptococcus mutans to modulate virulence expression in vivo. Antimicrob. Agents Chemother. 2012;56:6201-6211.
Not in our library10.1128/aac.01381-12
151.
Candida albicans mannans mediate Streptococcus mutans exoenzyme GtfB binding to modulate cross-kingdom biofilm development in vivo · 2017
No notice
152.
Willems M., Kos K., Jabra-Rizk M.A., Krom B. Candida albicans in oral biofilms could prevent caries. Pathog. Dis. 2016;74:ftw039.
Not in our library10.1093/femspd/ftw039
153.
Streptococcus mutans Can Modulate Biofilm Formation and Attenuate the Virulence of Candida albicans. · 2016
Not checked
154.
Xu H., Sobue T., Bertolini M., Thompson A., Dongari-Bagtzoglou A. Streptococcus oralis and Candida albicans synergistically activate μ-calpain to degrade e-cadherin from oral epithelial junctions. J. Infect. Dis. 2016;214:925-934.
Not in our library10.1093/infdis/jiw201
155.
Tamai R., Sugamata M., Kiyoura Y. Candida albicans enhances invasion of human gingival epithelial cells and gingival fibroblasts by Porphyromonas gingivalis. Microb. Pathog. 2011;51:250-254.
Not in our library10.1016/j.micpath.2011.06.009
156.
Janus M.M., Crielaard W., Volgenant C.M., van der Veen M.H., Brandt B.W., Krom B.P. Candida albicans alters the bacterial microbiome of early in vitro oral biofilms. J. Oral Microbiol. 2017;9:1270613.
Not in our library10.1080/20002297.2016.1270613
157.
Fuochi V., Li Volti G., Furneri P.M. Commentary: Lactobacilli dominance and vaginal pH: Why is the human vaginal microbiome unique? Front. Microbiol. 2017;8:1815.
Not in our library10.3389/fmicb.2017.01815
158.
Greenbaum S., Greenbaum G., Moran-Gilad J., Weintruab A.Y. Ecological dynamics of the vaginal microbiome in relation to health and disease. Am. J. Obstet. Gynecol. 2018;18:114-118.
Not in our library10.1016/j.ajog.2018.11.1089
159.
Vaneechoutte M. The human vaginal microbial community. Res. Microbiol. 2017;168:811-825.
Not in our library10.1016/j.resmic.2017.08.001
160.
Bradford L.L., Ravel J. The vaginal mycobiome: A contemporary perspective on fungi in women’s health and diseases. Virulence. 2017;8:342-351.
Not in our library10.1080/21505594.2016.1237332
161.
Sobel J.D., Faro S., Force R.W., Foxman B., Ledger W.J., Nyirjesy P.R., Reed B.D., Summers P.R. Vulvovaginal candidiasis: Epidemiologic, diagnostic, and therapeutic considerations. Am. J. Obstet. Gynecol. 1998;178:203-211.
Not in our library10.1016/s0002-9378(98)80001-x
162.
De Bernardis F., Graziani S., Tirelli F., Antonopoulou S. Candida vaginitis: Virulence, host response and vaccine prospects. Med. Mycol. 2018;56:26-31.
Not in our library10.1093/mmy/myx139
163.
Ferreira C., Alves C.T., Henriques M., Azeredo J., Silva S. Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors. Crit. Rev. Microbiol. 2016;42:905-927.
Not in our library10.3109/1040841x.2015.1091805
164.
Mendling W., Schwiertz A. Vaginal microbiota. Microbiota of the Human Body: Implications in Health and Disease. 2016;83-93.
Not in our library
165.
Probiotic Interference of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 with the Opportunistic Fungal Pathogen Candida albicans · 2012
No notice
166.
Nguyen L.N., Lopes L.C.L., Cordero R.J.B., Nosanchuk J.D. Sodium butyrate inhibits pathogenic yeast growth and enhances the functions of macrophages. J. Antimicrob. Chemother. 2011;66:2573-2580.
Not in our library10.1093/jac/dkr358
167.
Buffo J., Herman M.A., Soll D.R. A characterization of pH-regulated dimorphism in Candida albicans. Mycopathologia. 1984;85:21-30.
Not in our library10.1007/bf00436698
168.
De Barros P.P., Scorzoni L., Ribeiro F., Fugisaki L.R., Fuchs B.B., Mylonakis E., Jorge A.O., Junqueira J.C., Rossoni R.D. Lactobacillus paracasei 28.4 reduces in vitro hyphae formation of Candida albicans and prevents the filamentation in an experimental model of Caenorhabditis elegans. Microb. Pathog. 2018;117:80-87.
Not in our library10.1016/j.micpath.2018.02.019
169.
Latham T., Mackay L., Sproul D., Karim M., Culley J., Harrison D.J., Hayward L., Langridge-Smith P., Gilbert N., Ramsahoye B.H. Lactate, a product of glycolytic metabolism, inhibits histone deacetylase activity and promotes changes in gene expression. Nucleic Acids Res. 2012;40:4794-4803.
Not in our library10.1093/nar/gks066
170.
De Oliveira F.E., Rossoni R.D., de Barros P.P., Begnini B.E., Junqueira J.C., Jorge A.O.C., Leão M.V.P., de Oliveira L.D. Immunomodulatory effects and anti-Candida activity of lactobacilli in macrophages and in invertebrate model of Galleria mellonella. Microb. Pathog. 2017;110:603-611.
Not in our library10.1016/j.micpath.2017.08.006
171.
Ribeiro F.C., de Barros P.P., Rossoni R.D., Junqueira J.C., Jorge A.O.C. Lactobacillus rhamnosus inhibits Candida albicans virulence factors in vitro and modulates immune system in Galleria mellonella. J. Appl. Microbiol. 2017;122:201-211.
Not in our library10.1111/jam.13324
172.
Rossoni R.D., Fuchs B.B., de Barros P.P., Velloso M.d.S., Jorge A.O.C., Junqueira J.C., Mylonakis E. Lactobacillus paracasei modulates the immune system of Galleria mellonella and protects against Candida albicans infection. PLoS ONE. 2017;12:e0173332.
Not in our library10.1371/journal.pone.0173332
173.
Santos C.M.A., Pires M.C.V., Leão T.L., Silva A.K.S., Miranda L.S., Martins F.S., Silva A.M., Nicoli J.R. Anti-inflammatory effect of two Lactobacillus strains during infection with Gardnerella vaginalis and Candida albicans in a HeLa cell culture model. Microbiology. 2018;164:349-358.
Not in our library10.1099/mic.0.000608
174.
Ene I.V., Cheng S.-C., Netea M.G., Brown A.J.P. Growth of Candida albicans cells on the physiologically relevant carbon source lactate affects their recognition and phagocytosis by immune cells. Infect. Immun. 2013;81:238-248.
Not in our library10.1128/iai.01092-12
175.
Tachedjian G., Aldunate M., Bradshaw C.S., Cone R.A. The role of lactic acid production by probiotic Lactobacillus species in vaginal health. Res. Microbiol. 2017;168:782-792.
Not in our library10.1016/j.resmic.2017.04.001
176.
Zhang Z., Lv J., Pan L., Zhang Y. Roles and applications of probiotic Lactobacillus strains. Appl. Microbiol. Biotechnol. 2018;102:8135-8143.
Not in our library10.1007/s00253-018-9217-9
177.
McFarland L.V. From yaks to yogurt: The history, development, and current use of probiotics. Clin. Infect. Dis. 2015;60:85-90.
Not in our library10.1093/cid/civ054
178.
Hu H., Merenstein D.J., Wang C., Hamilton P.R., Blackmon M.L., Chen H., Calderone R.A., Li D. Impact of eating probiotic yogurt on colonization by Candida species of the oral and vaginal mucosa in HIV-infected and HIV-uninfected women. Mycopathologia. 2013;176:175-181.
Not in our library10.1007/s11046-013-9678-4
179.
Mezzasalma V., Manfrini E., Ferri E., Boccarusso M., Di Gennaro P., Schiano I., Michelotti A., Labra M. Orally administered multispecies probiotic formulations to prevent uro-genital infections: A randomized placebo-controlled pilot study. Arch. Gynecol. Obstet. 2017;295:163-172.
Not in our library10.1007/s00404-016-4235-2
180.
De Alberti D., Russo R., Terruzzi F., Nobile V., Ouwehand A. Lactobacilli vaginal colonisation after oral consumption of Respecta® complex: A randomised controlled pilot study. Arch. Gynecol. Obstet. 2015;292:861-867.
Not in our library10.1007/s00404-015-3711-4
181.
Reid G., Bruce A.W., Fraser N., Heinemann C., Owen J., Henning B. Oral probiotics can resolve urogenital infections. FEMS Immunol. Med. Microbiol. 2001;30:49-52.
Not in our library10.1111/j.1574-695x.2001.tb01549.x
182.
Verdenelli M.C., Cecchini C., Coman M.M., Silvi S., Orpianesi C., Coata G., Cresci A., Di Renzo G.C. Impact of probiotic SYNBIO® administered by vaginal suppositories in promoting vaginal health of apparently healthy women. Curr. Microbiol. 2016;73:483-490.
Not in our library10.1007/s00284-016-1085-x
183.
Kovachev S.M., Vatcheva-Dobrevska R.S. Local probiotic therapy for vaginal Candida albicans infections. Probiotics Antimicrob. Proteins. 2015;7:38-44.
Not in our library10.1007/s12602-014-9176-0
184.
Pendharkar S., Brandsborg E., Hammarström L., Marcotte H., Larsson P.-G. Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infection. BMC Infect. Dis. 2015;15:255.
Not in our library10.1186/s12879-015-0971-3
185.
De Seta F., Parazzini F., De Leo R., Banco R., Maso G.P., De Santo D., Sartore A., Stabile G., Inglese S., Tonon M., et al. Lactobacillus plantarum P17630 for preventing Candida vaginitis recurrence: A retrospective comparative study. Eur. J. Obstet. Gynecol. Reprod. Biol. 2014;182:136-139.
Not in our library10.1016/j.ejogrb.2014.09.018
186.
Cools P., Jespers V., Hardy L., Crucitti T., Delany-Moretlwe S., Mwaura M., Ndayisaba G.F., van de Wijgert J.H.H.M., Vaneechoutte M. A multi-country cross-sectional study of vaginal carriage of Group B Streptococci (GBS) and Escherichia coli in resource-poor settings: Prevalences and risk factors. PLoS ONE. 2016;11:e0148052.
Not in our library10.1371/journal.pone.0148052
187.
Yu X.-Y., Fu F., Kong W.-N., Xuan Q.-K., Wen D.-H., Chen X.-Q., He Y.-M., He L.-H., Guo J., Zhou A.-P., et al. Streptococcus agalactiae inhibits Candida albicans hyphal development and diminishes host vaginal mucosal TH17 response. Front. Microbiol. 2018;9:198.
Not in our library10.3389/fmicb.2018.00198
188.
Intestinal permeability – a new target for disease prevention and therapy · 2014
No notice
189.
Steimle A., Frick J.S. Molecular mechanisms of induction of tolerant and tolerogenic intestinal dendritic cells in mice. J. Immunol. Res. 2016;2016.
Not in our library10.1155/2016/1958650
190.
Budden K.F., Gellatly S.L., Wood D.L., Cooper M.A., Morrison M., Hugenholtz P., Hansbro P.M. Emerging pathogenic links between microbiota and the gut–lung axis. Nat. Rev. Microbiol. 2017;15:55-64.
Not in our library10.1038/nrmicro.2016.142
191.
Witherden E.A., Moyes D., Chatterjee S., Jungriathmyr W., Bagchi D. Mycobiome and gut inflammation: Implications in gut disease. Immunity and Inflammation in Health and Disease. 2017.
Not in our library
192.
Wu G.D., Chen J., Hoffmann C., Bittinger K., Chen Y.-Y., Keilbaugh S.A., Bewtra M., Knights D., Walters W.A., Knight R. Linking long-term dietary patterns with gut microbial enterotypes. Science. 2011;334:105-108.
Not in our library10.1126/science.1208344
193.
David L.A., Maurice C.F., Carmody R.N., Gootenberg D.B., Button J.E., Wolfe B.E., Ling A.V., Devlin A.S., Varma Y., Fischbach M.A. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505:559-563.
Not in our library10.1038/nature12820
194.
Age and Gender Affect the Composition of Fungal Population of the Human Gastrointestinal Tract · 2016
No notice
195.
Theriot C.M., Koenigsknecht M.J., Carlson P.E., Hatton G.E., Nelson A.M., Li B., Huffnagle G.B., Li J.Z., Young V.B. Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. Nat. Commun. 2014;5:3114.
Not in our library10.1038/ncomms4114
196.
Donaldson G.P., Lee S.M., Mazmanian S.K. Gut biogeography of the bacterial microbiota. Nat. Rev. Microbiol. 2016;14:20.
Not in our library10.1038/nrmicro3552
197.
Zhernakova A., Kurilshikov A., Bonder M.J., Tigchelaar E.F., Schirmer M., Vatanen T., Mujagic Z., Vila A.V., Falony G., Vieira-Silva S., et al. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science. 2016;352:565-569.
Not in our library10.1126/science.aad3369
198.
Qin J., Li R., Raes J., Arumugam M., Burgdorf K.S., Manichanh C., Nielsen T., Pons N., Levenez F., Yamada T. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464:59.
Not in our library10.1038/nature08821
199.
Bik E.M., Eckburg P.B., Gill S.R., Nelson K.E., Purdom E.A., Francois F., Perez-Perez G., Blaser M.J., Relman D.A. Molecular analysis of the bacterial microbiota in the human stomach. Proc. Natl. Acad. Sci. USA. 2006;103:732-737.
Not in our library10.1073/pnas.0506655103
200.
Durban A., Abellan J.J., Jimenez-Hernandez N., Ponce M., Ponce J., Sala T., D’Auria G., Latorre A., Moya A. Assessing gut microbial diversity from feces and rectal mucosa. Microb. Ecol. 2011;61:123-133.
Not in our library10.1007/s00248-010-9738-y
201.
Altomare A., Putignani L., Del Chierico F., Cocca S., Angeletti S., Ciccozzi M., Tripiciano C., Dalla Piccola B., Cicala M., Guarino M.P.L. Gut mucosal-associated microbiota better discloses Inflammatory Bowel Disease differential patterns than faecal microbiota. Dig. Liver Dis. 2018;18.
Not in our library10.1016/j.dld.2018.11.021
202.
Carstens A., Roos A., Andreasson A., Magnuson A., Agreus L., Halfvarson J., Engstrand L. Differential clustering of fecal and mucosa-associated microbiota in ‘healthy’ individuals. J. Dig. Dis. 2018;19:745-752.
Not in our library10.1111/1751-2980.12688
203.
Zoetendal E.G., Rajilic-Stojanovic M., de Vos W.M. High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut. 2008;57:1605-1615.
Not in our library10.1136/gut.2007.133603
204.
Seed P.C. The human mycobiome. Cold Spring Harb. Perspect. Med. 2014;5:a019810.
Not in our library10.1101/cshperspect.a019810
205.
Ott S.J., Kühbacher T., Musfeldt M., Rosenstiel P., Hellmig S., Rehman A., Drews O., Weichert W., Timmis K.N., Schreiber S. Fungi and inflammatory bowel diseases: Alterations of composition and diversity. Scand. J. Gastrol. 2008;43:831-841.
Not in our library10.1080/00365520801935434
206.
Lepage P., Seksik P., Sutren M., de la Cochetiere M.F., Jian R., Marteau P., Dore J. Biodiversity of the mucosa-associated microbiota is stable along the distal digestive tract in healthy individuals and patients with IBD. Inflamm. Bowel Dis. 2005;11:473-480.
Not in our library10.1097/01.mib.0000159662.62651.06
207.
Sepehri S., Kotlowski R., Bernstein C.N., Krause D.O. Microbial diversity of inflamed and noninflamed gut biopsy tissues in inflammatory bowel disease. Inflamm. Bowel Dis. 2007;13:675-683.
Not in our library10.1002/ibd.20101
208.
Conte M.P., Schippa S., Zamboni I., Penta M., Chiarini F., Seganti L., Osborn J., Falconieri P., Borrelli O., Cucchiara S. Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease. Gut. 2006;55:1760-1767.
Not in our library10.1136/gut.2005.078824
209.
Libertucci J., Young V.B. The role of the microbiota in infectious diseases. Nat. Microbiol. 2019;4:35.
Not in our library10.1038/s41564-018-0278-4
210.
Ubeda C., Djukovic A., Isaac S. Roles of the intestinal microbiota in pathogen protection. Clin. Transl. Immun. 2017;6:e128.
Not in our library10.1038/cti.2017.2
211.
Tipping the Balance: C. albicans Adaptation in Polymicrobial Environments · 2018
Not checked
212.
Clemente J.C., Ursell L.K., Parfrey L.W., Knight R. The impact of the gut microbiota on human health: An integrative view. Cell. 2012;148:1258-1270.
Not in our library10.1016/j.cell.2012.01.035
213.
Huffnagle G.B., Noverr M.C. The emerging world of the fungal microbiome. Trends Microbiol. 2013;21:334-341.
Not in our library10.1016/j.tim.2013.04.002
214.
Ianiro G., Tilg H., Gasbarrini A. Antibiotics as deep modulators of gut microbiota: Between good and evil. Gut. 2016;65:1906-1915.
Not in our library10.1136/gutjnl-2016-312297
215.
Sokol H., Leducq V., Aschard H., Pham H.-P., Jegou S., Landman C., Cohen D., Liguori G., Bourrier A., Nion-Larmurier I. Fungal microbiota dysbiosis in IBD. Gut. 2017;66:1039-1048.
Not in our library10.1136/gutjnl-2015-310746
216.
Angebault C., Ghozlane A., Volant S., Botterel F., D’enfert C., Bougnoux M.E. Combined bacterial and fungal intestinal microbiota analyses: Impact of storage conditions and DNA extraction protocols. PLoS ONE. 2018;13:e0201174.
Not in our library10.1371/journal.pone.0201174
217.
Skalski J.H., Limon J.J., Sharma P., Gargus M.D., Nguyen C., Tang J., Coelho A.L., Hogaboam C.M., Crother T.R., Underhill D.M. Expansion of commensal fungus Wallemia mellicola in the gastrointestinal mycobiota enhances the severity of allergic airway disease in mice. PLoS Pathog. 2018;14.
Not in our library10.1371/journal.ppat.1007260
218.
Scupham A.J., Presley L.L., Wei B., Bent E., Griffith N., McPherson M., Zhu F., Oluwadara O., Rao N., Braun J., et al. Abundant and diverse fungal microbiota in the murine intestine. Appl. Environ. Microbiol. 2006;72:793-801.
Not in our library10.1128/aem.72.1.793-801.2006
219.
Alterations in the gut bacterial microbiome in fungal Keratitis patients. · 2018
Not checked
220.
Wheeler M.L., Limon J.J., Bar A.S., Leal C.A., Gargus M., Tang J., Brown J., Funari V.A., Wang H.L., Crother T.R. Immunological consequences of intestinal fungal dysbiosis. Cell Host Microbe. 2016;19:865-873.
Not in our library10.1016/j.chom.2016.05.003
221.
Jiang T.T., Shao T.-Y., Ang W.G., Kinder J.M., Turner L.H., Pham G., Whitt J., Alenghat T., Way S.S. Commensal fungi recapitulate the protective benefits of intestinal bacteria. Cell Host Microbe. 2017;22:809-816.
Not in our library10.1016/j.chom.2017.10.013
222.
Mason K.L., Downward J.R.E., Mason K.D., Falkowski N.R., Eaton K.A., Kao J.Y., Young V.B., Huffnagle G.B. Candida albicans and bacterial microbiota interactions in the cecum during re-colonization following broad spectrum antibiotic therapy. Infect. Immun. 2012;80:3371-3380.
Not in our library10.1128/iai.00449-12
223.
Kennedy M.J., Volz P.A. Effect of various antibiotics on gastrointestinal colonization and dissemination by Candida albicans. J. Med. Vet. Mycol. 1985;23:265-273.
Not in our library10.1080/00362178585380391
224.
Noverr M.C., Falkowski N.R., McDonald R.A., McKenzie A.N., Huffnagle G.B. Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: Role of host genetics, antigen, and interleukin-13. Infect. Immun. 2005;73:30-38.
Not in our library10.1128/iai.73.1.30-38.2005
225.
Koh A.Y. Murine models of Candida gastrointestinal colonization and dissemination. Eukaryot. Cell. 2013;12:1416-1422.
Not in our library10.1128/ec.00196-13
226.
Fan D., Coughlin L.A., Neubauer M.M., Kim J., Kim M.S., Zhan X., Simms-Waldrip T.R., Xie Y., Hooper L.V., Koh A.Y. Activation of HIF-1alpha and LL-37 by commensal bacteria inhibits Candida albicans colonization. Nat. Med. 2015;21:808-814.
Not in our library10.1038/nm.3871
227.
Naglik J.R., Fidel P.L., Odds F.C. Animal models of mucosal Candida infection. FEMS Microbiol. Lett. 2008;283:129-139.
Not in our library10.1111/j.1574-6968.2008.01160.x
228.
Modulation of Post-Antibiotic Bacterial Community Reassembly and Host Response by Candida albicans · 2013
No notice
229.
López-García B., Lee P.H., Yamasaki K., Gallo R.L. Anti-fungal activity of cathelicidins and their potential role in Candida albicans skin infection. J. Investig. Dermatol. 2005;125:108-115.
Not in our library10.1111/j.0022-202x.2005.23713.x
230.
Charlet R., Pruvost Y., Tumba G., Istel F., Poulain D., Kuchler K., Sendid B., Jawhara S. Remodeling of the Candida glabrata cell wall in the gastrointestinal tract affects the gut microbiota and the immune response. Sci. Rep. 2018;8:3316.
Not in our library10.1038/s41598-018-21422-w
231.
Charlet R., Bortolus C., Barbet M., Sendid B., Jawhara S. A decrease in anaerobic bacteria promotes Candida glabrata overgrowth while beta-glucan treatment restores the gut microbiota and attenuates colitis. Gut Pathog. 2018;10:50-59.
Not in our library10.1186/s13099-018-0277-2
232.
Murphy A., Kavanagh K. Emergence of Saccharomyces cerevisiae as a human pathogen: Implications for biotechnology. Enzym. Microb. Technol. 1999;25:551-557.
Not in our library10.1016/s0141-0229(99)00086-1
233.
De Llanos R., Querol A., Pemán J., Gobernado M., Fernández-Espinar M.T. Food and probiotic strains from the Saccharomyces cerevisiae species as a possible origin of human systemic infections. Int. J. Food Microbiol. 2006;110:286-290.
Not in our library10.1016/j.ijfoodmicro.2006.04.023
234.
Byron J.K., Clemons K.V., McCusker J.H., Davis R.W., Stevens D.A. Pathogenicity of Saccharomyces cerevisiae in complement factor five-deficient mice. Infect. Immun. 1995;63:478-485.
Not in our library10.1128/iai.63.2.478-485.1995
235.
Munoz P., Bouza E., Cuenca-Estrella M., Eiros J.M., Pérez M.J., Sánchez-Somolinos M., Rincón C., Hortal J., Peláez T. Saccharomyces cerevisiae fungemia: An emerging infectious disease. Clin. Infect. Dis. 2005;40:1625-1634.
Not in our library10.1086/429916
236.
Massot J., Sanchez O., Couchy R., Astoin J., Parodi A.L. Bacterio-pharmacological activity of Saccharomyces boulardii in clindamycin-induced colitis in the hamster. Arzneimittel-Forschung. 1984;34:794-797.
Not in our library
237.
Kelesidis T., Pothoulakis C. Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders. Therap. Adv. Gastroenterol. 2012;5:111-125.
Not in our library10.1177/1756283x11428502
238.
Lessard M., Dupuis M., Gagnon N., Nadeau E., Matte J., Goulet J., Fairbrother J. Administration of Pediococcus acidilactici or Saccharomyces cerevisiae boulardii modulates development of porcine mucosal immunity and reduces intestinal bacterial translocation after Escherichia coli challenge. J. Anim. Sci. 2009;87:922-934.
Not in our library10.2527/jas.2008-0919
239.
Roussel C., Sivignon A., de Vallée A., Garrait G., Denis S., Tsilia V., Ballet N., Vandekerckove P., Van de Wiele T., Barnich N. Anti-infectious properties of the probiotic Saccharomyces cerevisiae CNCM I-3856 on enterotoxigenic E. coli (ETEC) strain H10407. Appl. Microbiol. Biotechnol. 2018;102:6175-6189.
Not in our library10.1007/s00253-018-9053-y
240.
Clostridium difficile Infection in Patients Discharged from US Short-stay Hospitals, 1996–20031 · 2006
No notice
241.
Corthier G., Dubos F., Ducluzeau R. Prevention of Clostridium difficile induced mortality in gnotobiotic mice by Saccharomyces boulardii. Can. J. Microbiol. 1986;32:894-896.
Not in our library10.1139/m86-164
242.
Gut fungal dysbiosis correlates with reduced efficacy of fecal microbiota transplantation in Clostridium difficile infection · 2018
No notice
243.
Oral Candida administration in a Clostridium difficile mouse model worsens disease severity but is attenuated by Bifidobacterium. · 2019
Not checked
244.
Markey L., Shaban L., Green E.R., Lemon K.P., Mecsas J., Kumamoto C.A. Pre-colonization with the commensal fungus Candida albicans reduces murine susceptibility to Clostridium difficile infection. Gut Microbes. 2018;9:497-509.
Not in our library10.1080/19490976.2018.1465158
245.
Mitchell A.B., Glanville A.R. The human respiratory microbiome: Implications and impact. Semin. Respir. Crit. Care Med. 2018;39:199-212.
Not in our library10.1055/s-0037-1617441
246.
Ingenito E., Solway J., McFadden E., Pichurko B., Bowman H., Michaels D., Drazen J. Indirect assessment of mucosal surface temperatures in the airways: Theory and tests. J. Appl. Physiol. 1987;63:2075-2083.
Not in our library10.1152/jappl.1987.63.5.2075
247.
West J.B. Regional differences in the lung. Chest. 1978;74:426-437.
Not in our library10.1378/chest.74.4.426
248.
Marsland B.J., Gollwitzer E.S. Host–microorganism interactions in lung diseases. Nat. Rev. Immunol. 2014;14:827.
Not in our library10.1038/nri3769
249.
Huang L., Cattamanchi A., Davis J.L., Boon S., Kovacs J., Meshnick S., Miller R.F., Walzer P.D., Worodria W., Masur H. HIV-associated Pneumocystis pneumonia. Proc. Am. Thorac. Soc. 2011;8:294-300.
Not in our library10.1513/pats.201009-062wr
250.
Sethi S., Murphy T.F. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N. Engl. J. Med. 2008;359:2355-2365.
Not in our library10.1056/nejmra0800353
251.
Montes-Cano M., De La Horra C., Dapena F., Mateos I., Friaza V., Respaldiza N., Muñoz-Lobato F., Medrano F., Calderon E., Varela J. Dynamic colonisation by different Pneumocystis jirovecii genotypes in cystic fibrosis patients. Clin. Microbiol. Infect. 2007;13:1008-1011.
Not in our library10.1111/j.1469-0691.2007.01789.x
252.
Chabé M., Aliouat-Denis C.-M., Delhaes L., Aliouat E.M., Viscogliosi E., Dei-Cas E. Pneumocystis: From a doubtful unique entity to a group of highly diversified fungal species. FEMS Yeast Res. 2011;11:2-17.
Not in our library10.1111/j.1567-1364.2010.00698.x
253.
Peterson J.C., Cushion M.T. Pneumocystis: Not just pneumonia. Curr. Opin. Microbiol. 2005;8:393-398.
Not in our library10.1016/j.mib.2005.06.010
254.
Pneumocystis jirovecii in General Population · 2005
No notice
255.
Ponce C.A., Gallo M., Bustamante R., Vargas S.L. Pneumocystis colonization is highly prevalent in the autopsied lungs of the general population. Clin. Infect. Dis. 2010;50:347-353.
Not in our library10.1086/649868
256.
The Airway Microbiota in Cystic Fibrosis: A Complex Fungal and Bacterial Community—Implications for Therapeutic Management · 2012
No notice
257.
Limper A.H., Thomas C.F., Anders R.A., Leof E.B. Interactions of parasite and host epithelial cell cycle regulation during Pneumocystis carinii pneumonia. J. Lab. Clin. Med. 1997;130:132-138.
Not in our library10.1016/s0022-2143(97)90089-5
258.
Cui L., Lucht L., Tipton L., Rogers M.B., Fitch A., Kessinger C., Camp D., Kingsley L., Leo N., Greenblatt R.M. Topographic diversity of the respiratory tract mycobiome and alteration in HIV and lung disease. Am. J. Respir. Crit. Care Med. 2015;191:932-942.
Not in our library10.1164/rccm.201409-1583oc
259.
Beck J.M., Schloss P.D., Venkataraman A., Twigg III H., Jablonski K.A., Bushman F.D., Campbell T.B., Charlson E.S., Collman R.G., Crothers K. Multicenter comparison of lung and oral microbiomes of HIV-infected and HIV-uninfected individuals. Am. J. Respir. Crit. Care Med. 2015;192:1335-1344.
Not in our library10.1164/rccm.201501-0128oc
260.
Morris A., Beck J.M., Schloss P.D., Campbell T.B., Crothers K., Curtis J.L., Flores S.C., Fontenot A.P., Ghedin E., Huang L. Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am. J. Respir. Crit. Care Med. 2013;187:1067-1075.
Not in our library10.1164/rccm.201210-1913oc
261.
Dickson R.P., Erb-Downward J.R., Huffnagle G.B. The role of the bacterial microbiome in lung disease. Expert Rev. Respir. Med. 2013;7:245-257.
Not in our library10.1586/ers.13.24
262.
Cui L., Morris A., Huang L., Beck J.M., Twigg III H.L., von Mutius E., Ghedin E. The microbiome and the lung. Ann. Am. Thorac. Soc. 2014;11:227-232.
Not in our library10.1513/annalsats.201402-052pl
263.
Segal L.N., Clemente J.C., Tsay J.-C.J., Koralov S.B., Keller B.C., Wu B.G., Li Y., Shen N., Ghedin E., Morris A. Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype. Nat. Microbiol. 2016;1:16031.
Not in our library10.1038/nmicrobiol.2016.31
264.
Robinson M., Daviskas E., Eberl S., Baker J., Chan H., Anderson S., Bye P. The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: A pilot study. Eur. Respir. J. 1999;14:678-685.
Not in our library10.1034/j.1399-3003.1999.14c30.x
265.
Hauser A.R., Jain M., Bar-Meir M., McColley S.A. Clinical significance of microbial infection and adaptation in cystic fibrosis. Clin. Microbiol. Rev. 2011;24:29-70.
Not in our library10.1128/cmr.00036-10
266.
Harrison F. Microbial ecology of the cystic fibrosis lung. J. Microbiol. 2007;153:917-923.
Not in our library10.1099/mic.0.2006/004077-0
267.
Gordee R.S., Matthews T.R. Systemic antifungal activity of pyrrolnitrin. J. Appl. Microbiol. 1969;17:690-694.
Not in our library10.1128/am.17.5.690-694.1969
268.
Kerr J. Inhibition of fungal growth by Pseudomonas aeruginosa and Pseudomonas cepacia isolated from patients with cystic fibrosis. J. Infect. 1994;28:305-310.
Not in our library10.1016/s0163-4453(94)91943-7
269.
Hogan D.A., Vik Å., Kolter R. A Pseudomonas aeruginosa quorum-sensing molecule influences Candida albicans morphology. Mol. Microbiol. 2004;54:1212-1223.
Not in our library10.1111/j.1365-2958.2004.04349.x
270.
Volatile Compounds Emitted by <named-content content-type="genus-species">Pseudomonas aeruginosa</named-content> Stimulate Growth of the Fungal Pathogen <named-content content-type="genus-species">Aspergillus fumigatus</named-content> · 2016
Not checked
271.
Ferreira J.A., Penner J.C., Moss R.B., Haagensen J.A., Clemons K.V., Spormann A.M., Nazik H., Cohen K., Banaei N., Carolino E. Inhibition of Aspergillus fumigatus and its biofilm by Pseudomonas aeruginosa is dependent on the source, phenotype and growth conditions of the bacterium. PLoS ONE. 2015;10:e0134692.
Not in our library10.1371/journal.pone.0134692
272.
Kaur J., Pethani B.P., Kumar S., Kim M., Sunna A., Kautto L., Penesyan A., Paulsen I.T., Nevalainen H. Pseudomonas aeruginosa inhibits the growth of Scedosporium aurantiacum, an opportunistic fungal pathogen isolated from the lungs of cystic fibrosis patients. Front. Microbiol. 2015;6:866.
Not in our library10.3389/fmicb.2015.00866
273.
Sedlacek L., Graf B., Schwarz C., Albert F., Peter S., Würstl B., Wagner S., Klotz M., Becker A., Haase G. Prevalence of Scedosporium species and Lomentospora prolificans in patients with cystic fibrosis in a multicenter trial by use of a selective medium. J. Cyst. Fibros. 2015;14:237-241.
Not in our library10.1016/j.jcf.2014.12.014
274.
Chen S.C.-A., Patel S., Meyer W., Chapman B., Yu H., Byth K., Middleton P.G., Nevalainen H., Sorrell T.C. Pseudomonas aeruginosa inhibits the growth of Scedosporium and Lomentospora in vitro. Mycopathologia. 2018;183:251-261.
Not in our library10.1007/s11046-017-0140-x
275.
Roux D., Gaudry S., Khoy-Ear L., Aloulou M., Phillips-Houlbracq M., Bex J., Skurnik D., Denamur E., Monteiro R.C., Dreyfuss D. Airway fungal colonization compromises the immune system allowing bacterial pneumonia to prevail. Crit. Care Med. 2013;41:191-199.
Not in our library10.1097/ccm.0b013e31828a25d6
276.
Ader F., Jawhara S., Nseir S., Kipnis E., Faure K., Vuotto F., Chemani C., Sendid B., Poulain D., Guery B. Short term Candida albicans colonization reduces Pseudomonas aeruginosa-related lung injury and bacterial burden in a murine model. J. Crit. Care. 2011;15:150.
Not in our library10.1186/cc10276
277.
Arvanitis M., Mylonakis E. Fungal–bacterial interactions and their relevance in health. Cell Microbiol. 2015;17:1442-1446.
Not in our library10.1111/cmi.12493
278.
Azoulay E., Timsit J.-F., Tafflet M., de Lassence A., Darmon M., Zahar J.-R., Adrie C., Garrouste-Orgeas M., Cohen Y., Mourvillier B. Candida colonization of the respiratory tract and subsequent Pseudomonas ventilator-associated pneumonia. Chest. 2006;129:110-117.
Not in our library10.1378/chest.129.1.110
279.
Kollef M.H., Shorr A., Tabak Y.P., Gupta V., Liu L.Z., Johannes R. Epidemiology and outcomes of health-care–associated pneumonia: Results from a large US database of culture-positive pneumonia. Chest. 2005;128:3854-3862.
Not in our library10.1378/chest.128.6.3854
280.
Holt K.E., Wertheim H., Zadoks R.N., Baker S., Whitehouse C.A., Dance D., Jenney A., Connor T.R., Hsu L.Y., Severin J. Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae, an urgent threat to public health. Proc. Natl. Acad. Sci. USA. 2015;112:3574-3581.
Not in our library10.1073/pnas.1501049112
281.
Podschun R., Ullmann U. Klebsiella spp. as nosocomial pathogens: Epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin. Microbiol. Rev. 1998;11:589-603.
Not in our library10.1128/cmr.11.4.589
282.
Stepwise evolution of pandrug-resistance in Klebsiella pneumoniae · 2015
No notice
283.
Genetic analysis of capsular polysaccharide synthesis gene clusters in 79 capsular types of Klebsiella spp · 2015
No notice
284.
Naparstek L., Carmeli Y., Navon-Venezia S., Banin E. Biofilm formation and susceptibility to gentamicin and colistin of extremely drug-resistant KPC-producing Klebsiella pneumoniae. Antimicrob. Agents Chemother. 2014;69:1027-1034.
Not in our library10.1093/jac/dkt487
285.
McConnell M.J., Actis L., Pachón J. Acinetobacter baumannii: Human infections, factors contributing to pathogenesis and animal models. FEMS Microbiol. Rev. 2013;37:130-155.
Not in our library10.1111/j.1574-6976.2012.00344.x
286.
Richards A.M., Abu Kwaik Y., Lamont R.J. Code blue: Acinetobacter baumannii, a nosocomial pathogen with a role in the oral cavity. Mol. Oral Microbiol. 2015;30:2-15.
Not in our library10.1111/omi.12072
287.
Tan X., Chen R., Zhu S., Wang H., Yan D., Zhang X., Farmakiotis D., Mylonakis E. Candida albicans airway colonization facilitates subsequent Acinetobacter baumannii pneumonia in a rat model. Antimicrob. Agents Chemother. 2016;60:3348-3354.
Not in our library10.1128/aac.02180-15
288.
Mendoza L., Vilela R., Voelz K., Ibrahim A.S., Voigt K., Lee S.C. Human fungal pathogens of Mucorales and Entomophthorales. Cold Spring Harb. Perspect. Med. 2014;5:a019562.
Not in our library10.1101/cshperspect.a019562
289.
Hassan M.I.A., Voigt K. Pathogenicity patterns of mucormycosis: Epidemiology, interaction with immune cells and virulence factors. Med. Mycol. 2019;57:245-256.
Not in our library10.1093/mmy/myz011
290.
Morace G., Borghi E. Invasive mold infections: Virulence and pathogenesis of Mucorales. Int. J. Med. Microbiol. 2012;2012:349278.
Not in our library10.1155/2012/349278
291.
Hover T., Maya T., Ron S., Sandovsky H., Shadkchan Y., Kijner N., Mitiagin Y., Fichtman B., Harel A., Shanks R.M., et al. Mechanisms of bacterial (Serratia marcescens) attachment to migration along, and killing of fungal hyphae. Appl. Environ. Microbiol. 2016;82:2585-2594.
Not in our library10.1128/aem.04070-15
292.
Ibrahim A.S., Gebremariam T., Liu M., Chamilos G., Kontoyiannis D., Mink R., Kwon-Chung K.J., Fu Y., Skory C.D., Edwards J.E., et al. Bacterial endosymbiosis is widely present among zygomycetes but does not contribute to the pathogenesis of mucormycosis. J. Infect. Dis. 2008;198:1083-1090.
Not in our library10.1086/591461
293.
Kobayashi D.Y., Crouch J.A. Bacterial/Fungal interactions: From pathogens to mutualistic endosymbionts. Annu. Rev. Phytopathol. 2009;47:63-82.
Not in our library10.1146/annurev-phyto-080508-081729
294.
Church D., Elsayed S., Reid O., Winston B., Lindsay R. Burn wound infections. Clin. Microbiol. Rev. 2006;19:403-434.
Not in our library10.1128/cmr.19.2.403-434.2006
295.
Byrd A.L., Belkaid Y., Segre J.A. The human skin microbiome. Nat. Rev. Microbiol. 2018;16:143-155.
Not in our library10.1038/nrmicro.2017.157
296.
Murphy K.P., Janeway C.A., Travers P., Walport M., Ehrenstein M., Schank D. The Complement System and Innate Immunity. Janeway’s Immunobiology. 2008.
Not in our library
297.
Macfarlane S., Dillon J.F. Microbial biofilms in the human gastrointestinal tract. J. Appl. Microbiol. 2007;102:1187-1196.
Not in our library10.1111/j.1365-2672.2007.03287.x
298.
Peters B.M., Ward R.M., Rane H.S., Lee S.A., Noverr M.C. Efficacy of ethanol against Candida albicans and Staphylococcus aureus polymicrobial biofilms. Antimicrob. Agents Chemother. 2013;57:74-82.
Not in our library10.1128/aac.01599-12
299.
Harriott M.M., Noverr M.C. Ability of Candida albicans mutants to induce Staphylococcus aureus vancomycin resistance during polymicrobial biofilm formation. Antimicrob. Agents Chemother. 2010;54:3746-3755.
Not in our library10.1128/aac.00573-10
300.
Siala W., Kucharikova S., Braem A., Vleugels J., Tulkens P.M., Mingeot-Leclercq M.P., Van Dijck P., Van Bambeke F. The antifungal caspofungin increases fluoroquinolone activity against Staphylococcus aureus biofilms by inhibiting N-acetylglucosamine transferase. Nat. Commun. 2016;7:13286.
Not in our library10.1038/ncomms13286
301.
Rogiers O., Holtappels M., Siala W., Lamkanfi M., Van Bambeke F., Lagrou K., Van Dijck P., Kucharikova S. Anidulafungin increases the antibacterial activity of tigecycline in polymicrobial Candida albicans/Staphylococcus aureus biofilms on intraperitoneally implanted foreign bodies. J. Antimicrob. Chemother. 2018;73:2806-2814.
Not in our library10.1093/jac/dky246
302.
Budič M., Rijavec M., Petkovšek Ž., Žgur-Bertok D. Escherichia coli bacteriocins: Antimicrobial efficacy and prevalence among isolates from patients with bacteraemia. PLoS ONE. 2011;6:e28769.
Not in our library10.1371/journal.pone.0028769
303.
Bell T., O’Grady N.P. Prevention of central line-associated bloodstream infections. Infect. Dis. Clin. N. Am. 2017;31:551-559.
Not in our library10.1016/j.idc.2017.05.007
304.
Dyess D.L., Garrison R.N., Fry D.E. Candida sepsis. Implications of polymicrobial blood-borne infection. Arch. Surg. 1985;120:345-348.
Not in our library10.1001/archsurg.1985.01390270083014
305.
Pletz M.W., Weis S., Forstner C., Wagenlehner F. Urosepsis. Der Urologe. 2018;57:79-92.
Not in our library10.1007/s00120-017-0559-1
306.
Gouba N., Drancourt M. Digestive tract mycobiota: A source of infection. Med. Mal Infect. 2015;45:9-16.
Not in our library10.1016/j.medmal.2015.01.007
307.
Inweregbu K. Nosocomial infections. CEACCP. 2005;5:14-17.
Not in our library10.1093/bjaceaccp/mki006
308.
Orsini J., Mainardi C., Muzylo E., Karki N., Cohen N., Sakoulas G. Microbiological profile of organisms causing bloodstream infection in critically ill patients. J. Clin. Med. Res. 2012;4:371-377.
Not in our library10.4021/jocmr1099w
309.
Bouza E., Burillo A., Munoz P., Guinea J., Marin M., Rodriguez-Creixems M. Mixed bloodstream infections involving bacteria and Candida spp. J. Antimicrob. Chemother. 2013;68:1881-1888.
Not in our library10.1093/jac/dkt099
310.
Klingspor L., Muhammed S.A., Ozenci V. Comparison of the two blood culture systems, Bactec 9240 and BacT/Alert 3D, in the detection of Candida spp. and bacteria with polymicrobial sepsis. Eur. J. Clin. Microbiol. Infect. Dis. 2012;31:2983-2987.
Not in our library10.1007/s10096-012-1650-6
311.
Kaufman D.A., Brown A.T., Eisenhuth K.K., Yue J., Grossman L.B., Hazen K.C. More serious infectious morbidity and mortality associated with simultaneous candidemia and coagulase-negative staphylococcal bacteremia in neonates and in vitro adherence studies between Candida albicans and Staphylococcus epidermidis. Early Hum. Dev. 2014;90:66-70.
Not in our library10.1016/s0378-3782(14)70021-0
312.
Pammi M., Zhong D., Johnson Y., Revell P., Versalovic J. Polymicrobial bloodstream infections in the neonatal intensive care unit are associated with increased mortality: A case-control study. BMC Infect. Dis. 2014;14:390.
Not in our library10.1186/1471-2334-14-390
313.
Cateau E., Cognee A.S., Tran T.C., Vallade E., Garcia M., Belaz S., Kauffmann-Lacroix C., Rodier M.H. Impact of yeast-bacteria coinfection on the detection of Candida spp. in an automated blood culture system. Diagn. Microbiol. Infect. Dis. 2012;72:328-331.
Not in our library10.1016/j.diagmicrobio.2011.12.012
314.
Hockey L.J., Fujita N.K., Gibson T.R., Rotrosen D., Montgomerie J.Z., Edwards J.E. Detection of fungemia obscured by concomitant bacteremia: In vitro and in vivo studies. J. Clin. Microbiol. 1982;16:1080-1085.
Not in our library10.1128/jcm.16.6.1080-1085.1982
315.
Pulimood S., Ganesan L., Alangaden G., Chandrasekar P. Polymicrobial candidemia. Diagn. Microbiol Infect. Dis. 2002;44:353-357.
Not in our library10.1016/s0732-8893(02)00460-1
316.
Nair N., Biswas R., Gotz F., Biswas L. Impact of Staphylococcus aureus on pathogenesis in polymicrobial infections. Infect. Immun. 2014;82:2162-2169.
Not in our library10.1128/iai.00059-14
317.
Luo Y., Cui M.Y., Liao B., Pui M.H., Dong Z., Li X.H., Sun C.H., Peng Z.P., Li Z.P., Feng S.T. Diagnostic and post-treatment CT appearance of biopsy proven mixed Cryptococcus and Candida cholangitis. J. Xray Sci. Technol. 2014;22:727-733.
Not in our library10.3233/xst-140457
318.
Sulis G., Villanacci V., Missale G., Salemme M., Castelli F., Caligaris S. Whipple’s disease concomitant with Candida esophagitis and subsequent Giardia lamblia coinfection. Eur. J. Gastroenterol. Hepatol. 2014;26:1181-1185.
Not in our library10.1097/meg.0000000000000154
319.
Failed Reverse Total Shoulder Arthroplasty Caused by Recurrent Candida glabrata Infection with Prior Serratia marcescens Coinfection · 2014
Not checked
320.
Carlson E. Enhancement by Candida albicans of Staphylococcus aureus, Serratia marcescens, and Streptococcus faecalis in the establishment of infection in mice. Infect. Immun. 1983;39:193-197.
Not in our library10.1128/iai.39.1.193-197.1983
321.
Carlson E. Effect of strain of Staphylococcus aureus on synergism with Candida albicans resulting in mouse mortality and morbidity. Infect. Immun. 1983;42:285-292.
Not in our library10.1128/iai.42.1.285-292.1983
322.
Peters B.M., Noverr M.C. Candida albicans-Staphylococcus aureus polymicrobial peritonitis modulates host innate immunity. Infect. Immun. 2013;81:2178-2189.
Not in our library10.1128/iai.00265-13
323.
Nash E.E., Peters B.M., Palmer G.E., Fidel P.L., Noverr M.C. Morphogenesis is not required for Candida albicans-Staphylococcus aureus intra-abdominal infection-mediated dissemination and lethal sepsis. Infect. Immun. 2014;82:3426-3435.
Not in our library10.1128/iai.01746-14
324.
Ikeh M.A.C., Fidel P.L., Noverr M.C. Identification of specific components of the eicosanoid biosynthetic and signaling pathway involved in pathological inflammation during intra-abdominal infection with Candida albicans and Staphylococcus aureus. Infect. Immun. 2018;86:e00144-18.
Not in our library10.1128/iai.00144-18
325.
Nash E.E., Peters B.M., Fidel P.L., Noverr M.C. Morphology-independent virulence of Candida species during polymicrobial intra-abdominal infections with Staphylococcus aureus. Infect. Immun. 2016;84:90-98.
Not in our library10.1128/iai.01059-15
326.
Lilly E.A., Ikeh M., Nash E.E., Fidel P.L., Noverr M.C. Immune protection against lethal fungal-bacterial intraabdominal infections. MBio. 2018;9:e01472-17.
Not in our library10.1128/mbio.01472-17
327.
Sawyer R.G., Adams R.B., Rosenlof L.K., May A.K., Pruett T.L. The role of Candida albicans in the pathogenesis of experimental fungal/bacterial peritonitis and abscess formation. Am. Surg. 1995;61:726-731.
Not in our library
328.
Klaerner H.G., Uknis M.E., Acton R.D., Dahlberg P.S., Carlone-Jambor C., Dunn D.L. Candida albicans and Escherichia coli are synergistic pathogens during experimental microbial peritonitis. J. Surg. Res. 1997;70:161-165.
Not in our library10.1006/jsre.1997.5110
329.
Stenutz R., Weintraub A., Widmalm G. The structures of Escherichia coli O-polysaccharide antigens. FEMS Microbiol. Rev. 2006;30:382-403.
Not in our library10.1111/j.1574-6976.2006.00016.x
330.
Akagawa G., Abe S., Yamaguchi H. Mortality of Candida albicans-infected mice is facilitated by superinfection of Escherichia coli or administration of its lipopolysaccharide. J. Infect. Dis. 1995;171:1539-1544.
Not in our library10.1093/infdis/171.6.1539
331.
Toscano M.G., Ganea D., Gamero A.M. Cecal ligation puncture procedure. J. Vis. Exp. 2011;4:31.
Not in our library10.3791/2860
332.
Maier S., Traeger T., Entleutner M., Westerholt A., Kleist B., Huser N., Holzmann B., Stier A., Pfeffer K., Heidecke C.D. Cecal ligation and puncture versus colon ascendens stent peritonitis: Two distinct animal models for polymicrobial sepsis. Shock. 2004;21:505-511.
Not in our library10.1097/01.shk.0000126906.52367.dd
333.
Davis C.G., Chang K., Osborne D., Walton A.H., Dunne W.M., Muenzer J.T. Increased susceptibility to Candida infection following cecal ligation and puncture. Biochem. Biophys. Res. Commun. 2011;414:37-43.
Not in our library10.1016/j.bbrc.2011.09.017
334.
Chen X.P., Zheng H., Li W.G., Chen G.D., Lu J.X. Bacteria-induced susceptibility to Candida albicans super-infection in mice via monocyte methyltransferase Setdb2. Cell Microbiol. 2018;20:e12860.
Not in our library10.1111/cmi.12860
335.
Panpetch W., Somboonna N., Bulan D.E., Issara-Amphorn J., Finkelman M., Worasilchai N., Chindamporn A., Palaga T., Tumwasorn S., Leelahavanichkul A. Oral administration of live- or heat-killed Candida albicans worsened cecal ligation and puncture sepsis in a murine model possibly due to an increased serum (1-->3)-beta-D-glucan. PLoS ONE. 2017;12:e0181439.
Not in our library10.1371/journal.pone.0181439
336.
Panpetch W., Somboonna N., Bulan D.E., Issara-Amphorn J., Worasilchai N., Finkelman M., Chindamporn A., Palaga T., Tumwasorn S., Leelahavanichkul A. Gastrointestinal colonization of Candida albicans increases serum (1-->3)-beta-D-glucan, without candidemia, and worsens cecal ligation and puncture sepsis in murine model. Shock. 2018;49:62-70.
Not in our library10.1097/shk.0000000000000896
337.
Leelahavanichkul A., Worasilchai N., Wannalerdsakun S., Jutivorakool K., Somparn P., Issara-Amphorn J., Tachaboon S., Srisawat N., Finkelman M., Chindamporn A. Gastrointestinal leakage detected by serum (1-->3)-beta-D-glucan in mouse models and a pilot study in patients with sepsis. Shock. 2016;46:506-518.
Not in our library10.1097/shk.0000000000000645
338.
He S., Hang J.P., Zhang L., Wang F., Zhang D.C., Gong F.H. A systematic review and meta-analysis of diagnostic accuracy of serum 1,3-beta-D-glucan for invasive fungal infection: Focus on cutoff levels. J. Microbiol. Immunol. Infect. 2015;48:351-361.
Not in our library10.1016/j.jmii.2014.06.009
339.
Goodridge H.S., Wolf A.J., Underhill D.M. Beta-glucan recognition by the innate immune system. Immunol. Rev. 2009;230:38-50.
Not in our library10.1111/j.1600-065x.2009.00793.x
340.
Askew D.S. Aspergillus fumigatus: Virulence genes in a street-smart mold. Curr. Opin. Microbiol. 2008;11:331-337.
Not in our library10.1016/j.mib.2008.05.009
341.
Latgé J.-P. Aspergillus fumigatus and aspergillosis. Clin. Microbiol. Rev. 1999;12:310-350.
Not in our library10.1128/cmr.12.2.310
342.
Rueping M.J., Vehreschild J.J., Cornely O.A. Invasive candidiasis and candidemia: From current opinions to future perspectives. Expert Opin. Investig. Drugs. 2009;18:735-748.
Not in our library10.1517/13543780902911440
343.
Pappas P.G., Lionakis M.S., Arendrup M.C., Ostrosky-Zeichner L., Kullberg B.J. Invasive candidiasis. Nat. Rev. Dis. Primers. 2018;4:18026.
Not in our library10.1038/nrdp.2018.26
344.
Niemiec M.J., Kapitan M., Polke M., Jacobsen I.D. Commensal to Pathogen Transition of Candida albicans. Reference Module in Life Sciences. 2017.
Not in our library
345.
Prieto D., Correia I., Pla J., Roman E. Adaptation of Candida albicans to commensalism in the gut. Future Microbiol. 2016;11:567-583.
Not in our library10.2217/fmb.16.1
346.
Sudbery P.E. Growth of Candida albicans hyphae. Nat. Rev. Microbiol. 2011;9:737-748.
Not in our library10.1038/nrmicro2636
347.
Ch’ng J.-H., Chong K.K., Lam L.N., Wong J.J., Kline K.A. Biofilm-associated infection by enterococci. Nat. Rev. Microbiol. 2018;1:82-94.
Not in our library10.1038/s41579-018-0107-z
348.
Vidal R.M., Muhsen K., Tennant S.M., Svennerholm A.-M., Sow S.O., Sur D., Zaidi A.K., Faruque A.S., Saha D., Adegbola R. Colonization factors among enterotoxigenic Escherichia coli isolates from children with moderate-to-severe diarrhea and from matched controls in the Global Enteric Multicenter Study (GEMS). PLoS Negl. Trop. Dis. 2019;13:e0007037.
Not in our library10.1371/journal.pntd.0007037
349.
Goldstein E.J.C., Tyrrell K.L., Citron D.M. Lactobacillus species: Taxonomic complexity and controversial susceptibilities. Clin. Infect. Dis. 2015;60:98-107.
Not in our library10.1093/cid/civ072
350.
Lactic Acid Bacteria and Their Bacteriocins: Classification, Biosynthesis and Applications against Uropathogens: A Mini-Review · 2017
No notice
351.
Valentini M., Gonzalez D., Mavridou D.A., Filloux A. Lifestyle transitions and adaptive pathogenesis of Pseudomonas aeruginosa. Curr. Opin. Microbiol. 2018;41:15-20.
Not in our library10.1016/j.mib.2017.11.006
352.
Gellatly S.L., Hancock R.E. Pseudomonas aeruginosa: New insights into pathogenesis and host defenses. Pathog. Dis. 2013;67:159-173.
Not in our library10.1111/2049-632x.12033
353.
Hejazi A., Falkiner F.R. Serratia marcescens. J. Med. Microbiol. 1997;46:903-912.
Not in our library10.1099/00222615-46-11-903
354.
Sandner-Miranda L., Vinuesa P., Cravioto A., Morales-Espinosa R. The genomic basis of intrinsic and acquired antibiotic resistance in the genus Serratia. Front. Microbiol. 2018;9:828.
Not in our library10.3389/fmicb.2018.00828
355.
Krismer B., Weidenmaier C., Zipperer A., Peschel A. The commensal lifestyle of Staphylococcus aureus and its interactions with the nasal microbiota. Nat. Rev. Microbiol. 2017;15:675-687.
Not in our library10.1038/nrmicro.2017.104
356.
Sause W.E., Buckley P.T., Strohl W.R., Lynch A.S., Torres V.J. Antibody-based biologics and their promise to combat Staphylococcus aureus infections. Trend Pharmacol. Sci. 2016;37:231-241.
Not in our library10.1016/j.tips.2015.11.008
357.
Engholm D.H., Kilian M., Goodsell D.S., Andersen E.S., Kjaergaard R.S. A visual review of the human pathogen Streptococcus pneumoniae. FEMS Microbiol. Rev. 2017;41:854-879.
Not in our library10.1093/femsre/fux037
358.
Sitkiewicz I. How to become a killer, or is it all accidental? Virulence strategies in oral streptococci. Mol. Oral Microbiol. 2018;33:1-12.
Not in our library10.1111/omi.12192
359.
Wollein Waldetoft K., Raberg L. To harm or not to harm? On the evolution and expression of virulence in group A streptococci. Trends Microbiol. 2014;22:7-13.
Not in our library10.1016/j.tim.2013.10.006

Cited by papers we hold 3

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.